Moleculin Biotech, Inc. (MBRX) has 12 identified peers for comparison in the Healthcare sector. Peers include AKTX, ALLR, ANEB, ANTX, ATXI, BPTH and others.
MBRX has a market capitalization of $2.95M, compared to an average peer market cap of $221.31M. MBRX is notably smaller than its average peer.
